Howard L. Kaufman, M.D.

Howard L. Kaufman, M.D.
161 Fort Washington Ave
New York NY, 10032
(212) 342-6042

Medical School:
Loyola Strich School of Medicine 1986
Residency:
Boston University School of Medicine 1995
Fellowship:
National Cancer Institute, MD 1997
Board Certification:
General Surgery 1996
Hospital Affiliation:
New York Presbyterian/Columbia
Number of years at current affiliation:
5 years
Admit Patients to:
New York Presbyterian/Columbia
Faculty Affiliation:
Columbia University
Other cancers treated:
melanoma, sarcoma
Member of:
Southwest Oncology Group (SWOG)
American College of Surgeons Oncology Group (ACOSOG)
Website:
http://www.tumorvaccines.com
Publications (website):
http://www.tumorvaccines.com/publications.html
Foreign Languages spoken:
Spanish, French
Number of kidney cancer patients seen in 2006:
85
Prescribes High-Dose Interleukin-2?:
Yes
Current and Proposed Clinical Trials:
Trovax vaccine and IL-2
Comment:
We provide comprehensive care for patients with renal cell cancer, including surgery, high-dose interleukin-2, tyrosine kinase inhibitors, and clinical trials. We also have access to all consultation and support services such as neurosurgery, nephrology, nutrition, social services, and alternative medicine.